Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Down 13.4% in October

Check-Cap Ltd. (NASDAQ:CHEK) was the target of a significant drop in short interest in the month of October. As of October 31st, there was short interest totalling 14,200 shares, a drop of 13.4% from the October 15th total of 16,400 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average daily trading volume, of 14,900 shares, the short-interest ratio is presently 1.0 days.

Check-Cap Price Performance

CHEK stock traded down $0.03 during midday trading on Friday, hitting $0.77. The stock had a trading volume of 25,887 shares, compared to its average volume of 84,356. The business has a 50-day moving average of $1.37 and a two-hundred day moving average of $1.82. The firm has a market cap of $4.53 million, a price-to-earnings ratio of -0.26 and a beta of 0.39. Check-Cap has a 52-week low of $0.76 and a 52-week high of $3.85.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Check-Cap in a research report on Saturday, November 9th. They set a “sell” rating on the stock.

About Check-Cap

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.